bisbenzimidazole has been researched along with Hyperglycemia, Postprandial in 1 studies
Bisbenzimidazole: A benzimidazole antifilarial agent; it is fluorescent when it binds to certain nucleotides in DNA, thus providing a tool for the study of DNA replication; it also interferes with mitosis.
Hyperglycemia, Postprandial: Abnormally high BLOOD GLUCOSE level after a meal.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Patel, SR | 1 |
| Kvols, LK | 1 |
| Rubin, J | 1 |
| O'Connell, MJ | 1 |
| Edmonson, JH | 1 |
| Ames, MM | 1 |
| Kovach, JS | 1 |
1 trial available for bisbenzimidazole and Hyperglycemia, Postprandial
| Article | Year |
|---|---|
Phase I-II study of pibenzimol hydrochloride (NSC 322921) in advanced pancreatic carcinoma.
Topics: Adult; Bisbenzimidazole; Carcinoma, Intraductal, Noninfiltrating; Drug Administration Schedule; Drug | 1991 |